Drugs / P501-AS15
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00148928 | Mar 2005 → Nov 2006 | prostate cancer | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P501-AS15 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00148928 ↗ |
| Modality | Vaccine | “P501-AS15 vaccine” NCT00148928 ↗ |